Related Experiment Video
Updated: Aug 18, 2026

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
Published on: April 21, 2022
Malignant peritoneal mesothelioma
1Azienda per i Servizi Sanitari 2 Isontina, Ospedali di Monfalcone e Gorizia, Unità Operativa Complessa di Oncologia, Monfalcone, GO, Italy. oncologiamn@ass2.sanita.fvg.it
Background:
The clinical characteristics of malignant peritoneal mesothelioma are not fully known, and it appears as a variable entity with different types of clinical presentation and with a difficult diagnosis.
Patients:
Fifteen patients with malignant peritoneal mesothelioma were analyzed for asbestos exposure, clinical presentation, thrombocytosis, X-rays and echotomographic findings, peritoneal fluid cytology, surgical investigations, diagnosis in vita, therapy, cause of death, diagnosis time, and survival time.
Results:
Asbestos exposure was present in 12 men. Abdominal pain, ascites, abdominal mass, weight loss and fever were the most common presentation symptoms. In 5 patients, the disease presented as a surgical emergency. Assembling the presenting symptoms, malignant peritoneal mesothelioma was subdivided in 3 types: classical (6 cases), surgical (5 cases) and medical (4 cases). Thrombocytosis was present in 11 cases. Peritoneal fluid cytology was positive for neoplastic mesothelial cells in 8 of 10 cases. Laparotomy (5 patients) and laparoscopy (7 cases) were diagnostic in all cases. Diagnosis in vita was malignant peritoneal mesothelioma for 13 patients, peritoneal carcinomatosis for 1, with only 1 autopsy diagnosis. Seven patients were treated with chemotherapy, showing a progression of the disease. Mean symptoms-to-diagnosis time was 122 days (4-410), and mean symptoms-to-survival time was 345 days (45-1510).
Conclusions:
Malignant peritoneal mesothelioma is a very unusual disease characterized by a difficult diagnosis, a rapid evolution, a poor response to therapy, and a very high prevalence of thrombocytosis. A new clinical classification into three types (classical, surgical and medical) may be useful for a correct diagnosis. The early diagnosis of malignant peritoneal mesothelioma remains an important open question.
Insights
Malignant peritoneal mesothelioma is a rare cancer with challenging diagnosis and rapid progression. This study introduces a new classification system to aid in early detection and management of this aggressive disease.
Area of Science:
- Oncology
- Pathology
- Medical Diagnostics
Background:
- Malignant peritoneal mesothelioma is an uncommon malignancy with poorly understood clinical features.
- The disease presents variably, making diagnosis difficult and often delayed.
Purpose of the Study:
- To elucidate the clinical characteristics of malignant peritoneal mesothelioma.
- To investigate diagnostic methods, treatment responses, and survival outcomes.
- To propose a novel clinical classification for improved diagnosis.
Main Methods:
- Retrospective analysis of 15 patients diagnosed with malignant peritoneal mesothelioma.
- Evaluation of asbestos exposure, clinical presentation, laboratory findings (thrombocytosis), imaging, peritoneal fluid cytology, and surgical interventions.
- Analysis of diagnosis time, treatment efficacy, and survival duration.
Main Results:
- Asbestos exposure was noted in 12 male patients.
- Common symptoms included abdominal pain, ascites, mass, weight loss, and fever; 5 cases presented as surgical emergencies.
- Thrombocytosis was present in 11 patients; cytology confirmed malignancy in 8/10 cases. A new classification (classical, surgical, medical) was proposed. Mean diagnosis time was 122 days, and mean survival was 345 days.
Conclusions:
- Malignant peritoneal mesothelioma is characterized by diagnostic difficulty, rapid progression, poor therapeutic response, and high thrombocytosis prevalence.
- A new clinical classification (classical, surgical, medical) may enhance diagnostic accuracy.
- Early diagnosis of malignant peritoneal mesothelioma remains a critical unmet need.
More Related Videos
Related Concept Videos
Pleural Disorders: Types and Brief Description
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

